Design and production of a novel chimeric human growth hormone superagonist fused to human Fc domain
Background and purpose: Growth hormone (GH) has been known as a crucial metabolic hormone expressed at the pituitary and the other number of cells and tissues and responsible for body growth. Because of the short half-life of GH, daily subcutaneous injections were shown to be more effective for GH t...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Wolters Kluwer Medknow Publications
2022-01-01
|
| Edice: | Research in Pharmaceutical Sciences |
| Témata: | |
| On-line přístup: | http://www.rpsjournal.net/article.asp?issn=1735-5362;year=2022;volume=17;issue=3;spage=284;epage=293;aulast=Mirbaha |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
